- Home
- JAGX vs NVVE Comparison
JAGX vs NVVE Comparison
Compare JAGX & NVVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAGX
- NVVE
- Stock Information
- Founded
- JAGX 2013
- NVVE 1996
- Country
- JAGX United States
- NVVE United States
- Employees
- JAGX N/A
- NVVE N/A
- Industry
- JAGX Biotechnology: Pharmaceutical Preparations
- NVVE Oil Refining/Marketing
- Sector
- JAGX Health Care
- NVVE Energy
- Exchange
- JAGX Nasdaq
- NVVE Nasdaq
- Market Cap
- JAGX 3.1M
- NVVE 3.7M
- IPO Year
- JAGX N/A
- NVVE N/A
- Fundamental
- Price
- JAGX $4.46
- NVVE $0.97
- Analyst Decision
- JAGX
- NVVE
- Analyst Count
- JAGX 0
- NVVE 0
- Target Price
- JAGX N/A
- NVVE N/A
- AVG Volume (30 Days)
- JAGX 40.9K
- NVVE 178.6K
- Earning Date
- JAGX 03-31-2025
- NVVE 03-31-2025
- Dividend Yield
- JAGX N/A
- NVVE N/A
- EPS Growth
- JAGX N/A
- NVVE N/A
- EPS
- JAGX N/A
- NVVE N/A
- Revenue
- JAGX $11,689,000.00
- NVVE $5,286,229.00
- Revenue This Year
- JAGX $18.18
- NVVE $200.61
- Revenue Next Year
- JAGX $40.06
- NVVE $109.43
- P/E Ratio
- JAGX N/A
- NVVE N/A
- Revenue Growth
- JAGX 19.75
- NVVE N/A
- 52 Week Low
- JAGX $4.40
- NVVE $1.00
- 52 Week High
- JAGX $540.00
- NVVE $17.30
- Technical
- Relative Strength Index (RSI)
- JAGX 20.11
- NVVE 27.69
- Support Level
- JAGX $4.41
- NVVE $1.53
- Resistance Level
- JAGX $4.97
- NVVE $1.16
- Average True Range (ATR)
- JAGX 0.74
- NVVE 0.14
- MACD
- JAGX 0.22
- NVVE -0.01
- Stochastic Oscillator
- JAGX 3.95
- NVVE 8.00
About JAGX Jaguar Health Inc.
Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.
About NVVE Nuvve Holding Corp.
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.